Abstract
Cysteine endopeptidases regulate many physiological processes in the body and their impaired function may lead to several diseases. One of the methods of treating such diseases is achieved by controlling the proteolytic activity of these enzymes by using enzyme inhibition. This manuscript focuses on the mechanism of action of Papain, a cysteine endopeptidase enzyme and its inhibition using images generated with RasMol, which is one of the most popular graphics programs for the display of macromolecules like proteins and nucleic acid structures. The location of active site residues on the papain enzyme molecule is described with the RasMol images and the mode of inhibition of these active sites is described in reference with few examples of papain inhibitors. Thus, the manuscript discusses the use of RasMol program to understand the inhibition of cysteine endopeptidase enzyme papain.
Keywords: Papain, RasMol, cysteine, endopeptidase, enzyme, protease, inhibitors, protein data bank
Current Proteomics
Title: A RasMol study of the Mechanism of Inhibition of Cysteine Endopeptidase Enzyme Papain
Volume: 6 Issue: 3
Author(s): Karthikeyan Subramani
Affiliation:
Keywords: Papain, RasMol, cysteine, endopeptidase, enzyme, protease, inhibitors, protein data bank
Abstract: Cysteine endopeptidases regulate many physiological processes in the body and their impaired function may lead to several diseases. One of the methods of treating such diseases is achieved by controlling the proteolytic activity of these enzymes by using enzyme inhibition. This manuscript focuses on the mechanism of action of Papain, a cysteine endopeptidase enzyme and its inhibition using images generated with RasMol, which is one of the most popular graphics programs for the display of macromolecules like proteins and nucleic acid structures. The location of active site residues on the papain enzyme molecule is described with the RasMol images and the mode of inhibition of these active sites is described in reference with few examples of papain inhibitors. Thus, the manuscript discusses the use of RasMol program to understand the inhibition of cysteine endopeptidase enzyme papain.
Export Options
About this article
Cite this article as:
Subramani Karthikeyan, A RasMol study of the Mechanism of Inhibition of Cysteine Endopeptidase Enzyme Papain, Current Proteomics 2009; 6 (3) . https://dx.doi.org/10.2174/157016409789351860
DOI https://dx.doi.org/10.2174/157016409789351860 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Promising Pharmacological, Molecular and Cellular Treatments of Autoimmune Hepatitis
Current Pharmaceutical Design Anti-Androgen Drugs in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review
Current Medicinal Chemistry A Novel Fluorescence-Labeled Curcumin Conjugate: Synthesis, Evaluation and Imaging on Human Cell Lines
Current Pharmaceutical Design Elderly Hypertensive Patients: Silent White Matter Lesions, Blood Pressure Variability, Baroreflex Impairment and Cognitive Deterioration
Current Hypertension Reviews Endotherapia
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Soy Isoflavones and Cardiovascular Health: An Update
Current Nutrition & Food Science Differential Up-Regulation of Ammonia Detoxifying Enzymes in Cerebral Cortex, Cerebellum, Hippocampus, Striatum and Liver in Hyperammonemia
CNS & Neurological Disorders - Drug Targets Hyper-Coagulable Profile with Elevated Pro-Thrombotic Biomarkers and Increased Cerebro- and Cardio-Vascular Disease Risk Exist Among Healthy Dyslipidemic Women
Current Neurovascular Research Tachykinin Receptors as Therapeutic Targets in Stress-Related Disorders
Current Pharmaceutical Design Meet Our Regional Editor
CNS & Neurological Disorders - Drug Targets The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review
Current Neuropharmacology Potential Interactions between miRNAs and Hypoxia: A New Layer in Cancer Hypoxia
Anti-Cancer Agents in Medicinal Chemistry Central Nervous System Depressants and Risk of Hospitalization due to Community-Acquired Pneumonia in very Old Patients
Current Drug Safety Post Marketing Surveillance on Safety and Efficacy of IMOD in Iranian Patients with HIV/AIDS
Infectious Disorders - Drug Targets Malaria Chemotherapy: Recent Advances in Drug Development
Recent Patents on Anti-Infective Drug Discovery Pulmonary Arterial Hypertension in HIV-infected Patients
Current Hypertension Reviews A Critical Review of Treatment Approaches for Gambling Disorders
Current Drug Abuse Reviews Low-Dose Mercury Exposure in Early Life: Relevance of Thimerosal to Fetuses, Newborns and Infants
Current Medicinal Chemistry P-gp Transporter and its Role in Neurodegenerative Diseases
Current Topics in Medicinal Chemistry Cannabinoids for the Treatment of Schizophrenia: An Overview
Current Topics in Medicinal Chemistry